{"text_format":"1","workbook":"xlsx","n_sheets":1,"sheets":["CF_E"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"CF_E","index":0,"n_rows":58,"n_cols":3,"rows_kept":58,"cut":false,"hidden":false,"merged":[[2,0,2,1]]}
[]
["Consolidated statement of cash flows (IFRS)"]
["from 1 October 2016 to 30 September 2017"]
[null,"2016/17\n1 Oct 16 to 30 Sep 17","2015/16\n1 Oct 15 to 30 Sep 16"]
[null,"€ k","€ k"]
["Cash flows from operating activities:"]
["Consolidated profit",135778,99970]
["Adjustments to reconcile consolidated profit to net cash \nprovided by / (used in) operating activities"]
["Income taxes",52778,41991]
["Interest income / expenses",1759,2514]
["Results from investments accounted for using the equity method",0,810]
["       Results from other investments ",-39,-34]
["Result from disposal of hydrophilic IOL business Aaren Inc.",-7478,0]
["Depreciation and amortisation",24235,20226]
["Gains / losses on disposal of fixed assets ",249,303]
["       Dividends received",25,34]
["Interest received",770,630]
["Interest paid",-1559,-1565]
["Refunded income taxes",8700,772]
["Income taxes paid",-63430,-43020]
["Changes in working capital:"]
["Trade receivables",-48981,-2562]
["Inventories",-33381,-15183]
["Other assets",-18874,-4391]
["Trade payables",15271,19158]
["Provisions and financial liabilities",-26704,-2958]
["Other liabilities",-1387,-4925]
["Total adjustments",-98046,11800]
["Net cash provided by / (used in) operating activities",37732,111770]
["Cash flows from investing activities::"]
["Investment in property, plant and equipment",-13656,-12796]
["Investment in other intangible assets",-25366,-15121]
["Proceeds from fixed assets",489,338]
["Purchase of investments accounted for using the equity method and assets",0,-4131]
["Proceeds from sale of investments",16,0]
["Payments for other loans",-4074,-958]
["Proceeds from fixed-term deposits",0,110000]
["Investment in securities",-4413,0]
["Purchase of shares in affiliated non-consolidated companies",-12181,0]
["Purchase of shares in affiliated consolidated companies, net of cash acquired",-6035.3068192565988,0]
["Proceeds from disposal of hydrophilic IOL business Aaren Inc.",9289,0]
["Net cash provided by / (used in) investing activities",-55931.306819256599,77332]
["Cash flows from financing activities:"]
["Proceeds from / (repayment of) current liabilities to banks",219,-32]
["Proceeds from / (repayment of) non-current liabilities to banks",-466,-391]
["(Increase) / decrease in treasury receivables",-277249,-153383]
["Increase / (decrease) in treasury payables",45234,-7505]
["Increase / (decrease) in liabilities due to finance lease",-2876,-2812]
["      Dividend payments to shareholders of Carl Zeiss Meditec AG",-37565,-30898]
["Dividend payments to non-controlling interests",-26264,0]
["Proceeds from capital increase (net)",315036.48448799993,0]
["Payments of costs in connection with capital increase ",-1575,0]
["Net cash provided by / (used in) financing activities",14494.484487999929,-195021]
["Effect of exchange rate fluctuation on cash and cash equivalents",-1080,1588]
["Net increase / (decrease)  in cash and cash equivalents",-4784.8223312566697,-4331]
["Cash and cash equivalents, beginning of reporting period",8710,13041]
["Cash and cash equivalents, end of reporting period",3925.1776687433303,8710]
["The following notes are an integral part of the audited consolidated financial statements."]